Core Viewpoint - Dolly Varden Silver Corporation has entered into an agreement with underwriters for a total gross proceeds of $30,034,000 through a combination of securities offerings [1][2]. Group 1: Offering Details - The LIFE Offering will consist of Common Shares and CFT Shares, generating gross proceeds of $15,084,000, contributing to the total gross proceeds of $30,034,000 [2]. - The underwriters have an option to increase the size of the offerings by up to 15% to cover overallotments, exercisable up to 2 business days before closing [2]. - The offerings are expected to close around October 23, 2025, pending necessary regulatory approvals from the TSX Venture Exchange and NYSE American [4]. Group 2: Use of Proceeds - Net proceeds from the sale of Common Shares will be allocated for working capital and general corporate purposes [3]. - Gross proceeds from CFT Shares and FT Shares will be directed towards exploration, mineral resource expansion, and drilling at the Kitsault Valley project, along with working capital as permitted [3]. Group 3: Share Details - The offerings include 2,300,000 Common Shares at $6.50 each, 750,000 CFT Shares at $9.42 each, and 990,000 FT Shares at $8.10 each [8]. - FT Shares will be offered to accredited investors with a statutory hold period of four months and one day from closing [6]. Group 4: Existing Agreements - Hecla Canada Ltd. and Fury Gold Mines Ltd. have the right to acquire Common Shares at $6.50 each to maintain their pro rata equity interests in the Company [7].

He also leads the investing group IPO Edge , which offers actionable information on growth stocks through first-look IPO filings, previews on upcoming IPOs, an IPO calendar for tracking what’s on the horizon, a database of U.S. IPOs, and a guide to IPO investing to walk you through the entire IPO lifecycle - from filing to listing to quiet period and lockup expiration dates.Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initi ...

**NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES** VANCOUVER, British Columbia, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Domestic Metals Corp. (the “Company” or “Domestic Metals”) - (TSXV: DMCU; OTCQB: DMCUF; FSE: 03E) announces that, as a result of strong investor demand, the Company has increased the size of its previously announced non-brokered private placement pursuant to Part 5A of National Instrument 45-106 – Prospectus Exemptions (“NI 45-106”), as amend ...

Accessibility StatementSkip Navigation Vibativ  treats patients with pneumonia and serious skin infections NASHVILLE, Tenn. and RIYADH, Saudi Arabia, Sept. 29, 2025 /PRNewswire/ -- Specialty pharmaceutical companies Tabuk Pharmaceutical Manufacturing Company a fully owned subsidiary of Astra Industrial Group and a leading pharmaceutical company in the Middle East and Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, today announced the launch of Cumberland's Vibativ (telav ...

Core Insights - Ethos Technologies has filed for an initial public offering (IPO) with the US SEC, planning to list its Class A common stock on the Nasdaq under the ticker 'LIFE' [1] - The company's platform aims to streamline the insurance industry's value chain, enhancing processes from distribution to underwriting and payments [1][2] - The IPO is intended to improve the company's capital structure and create a public market for its shares [3] Company Overview - Ethos Technologies consolidates various insurance sales and administrative processes into a single platform, allowing for the development of insurance products and adjustments in underwriting and pricing [2] - The platform enhances the application process for consumers and agents, reducing errors through real-time validation against third-party data [2] - The underwriting engine utilizes predictive analytics and real-time data for risk assessment and policy issuance [2] Financial Aspects - A portion of the net proceeds from the IPO will be allocated to anticipated tax obligations related to RSU net settlement, with the remainder designated for general corporate purposes, including potential acquisitions or strategic investments [4] - Specific details regarding the number of shares to be offered and the price range have not yet been disclosed [4] Underwriting and Legal Counsel - The IPO will be managed by a consortium of underwriters led by Goldman Sachs & Co. and J.P. Morgan Securities, along with other financial institutions [5] - Legal counsel for the offering includes Cooley for Ethos Technologies and Simpson Thacher & Bartlett for the underwriters [5] Market Context - Recently, Neptune Insurance Holdings launched its IPO in the US, aiming to raise up to $368.4 million, with a share price range set at $18–20 for 18.42 million shares [6]

Core Insights - The U.S. IPO market is experiencing a modest scale with more companies entering, highlighted by a recent IPO and several SPACs debuting [1] - Megan Holdings, a Malaysian aquaculture service provider, priced its IPO at the lower end of its range, raising $5 million with a market cap of $65 million [1][2] - The week saw significant fundraising from SPACs, with Drugs Made In America Acquisition II raising $500 million, and other SPACs led by notable figures like Chamath Palihapitiya and Tom Lee also securing substantial amounts [1][2] IPO Activity - Megan Holdings (MGN) raised $5 million with a market cap of $55 million, showing a first-day return of +21% [2] - American Acquisition A (AEXA) raised $300 million, with a first-day return of +6% [2] - FutureCrest Acquisition (FRCS.U) raised $250 million, achieving a first-day return of +4% [2] - Emmis Acquisition (EMISU) raised $100 million, with no first-day return [2] - Drugs Made In America Acquisition II (DMIIU) raised $500 million, with a first-day return of +10% [2] Upcoming IPOs - Fermi (FRMI), a newly established REIT, plans to raise $500 million with a market cap of $13 billion, focusing on a large-scale data center project [5] - Neptune Insurance (NP) aims to raise $350 million with a market cap of $2.8 billion, providing data-driven insurance products [5] - Commercial Bancgroup (CBK) plans to raise $100 million with a market cap of $367 million [6] - HW Electro (HWEP) is set to raise $17 million with a market cap of $16.9 million [6] Initial Filings - Six IPOs submitted initial applications, including HCI Group Exzeo (XZO) seeking $100 million and Ethos Technologies (LIFE) also targeting $100 million [2][4] - Other companies filing include YCS Group Holdings (YCSG.RC) for $14 million, PressLogic (PLAI) for $12 million, Seahawk Recycling Holdings for $10 million, and CSC Collective Holdings for $7 million [2][4] SPAC Filings - Three SPACs filed initial applications, including Lafayette Digital Acquisition I seeking $250 million, Climate Transition Special Opportunities SPAC I aiming for $150 million, and Creative Future Acquisition targeting $60 million [3][4]

这家总部位于加利福尼亚州旧金山的公司成立于 2016 年，截至 2025 年 6 月 30 日的 12 个月期间营收达 3.2 亿美元。该公司计划在纳斯达克上市，股票代码为 LIFE。Ethos Technologies于 2025 年 6 月 12 日秘 密提交了上市申请。高盛、摩根大通、美国银行证券、巴克莱、花旗、德意志银行、Citizens JMP、威 廉布莱尔和贝尔德是此次交易的联合承销商。该公司尚未披露定价条款。 智通财经APP获悉，在线人寿保险交易及分析平台服务商Ethos Technologies(LIFE.US)于上周五向美国证 券交易委员会提交申请，计划通过首次公开募股筹集至多 1 亿美元资金。 该公司运营着一个数字化平台，该平台集成了人寿保险的分销、承保、保单签发、支付和管理等功能。 该平台负责处理消费者的申请和服务，为代理人提供销售和保单管理工具，并为承保方提供承保和管理 支持。截至 2025 年 6 月 30 日，该平台已激活了 45 万份保单。 ...

AUSTIN, Texas, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Ethos, a leading life insurance technology company on a mission to democratize access to life insurance, today announced that it filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to a proposed initial public offering of its Class A common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. Ethos intends to list its Class A common stock ...

Core Insights - Ethos Technologies experienced a 55% increase in revenue in the first half of 2025, reflecting a strong performance in the insurance IPO market [1] - The company reported a net income of $30.7 million on revenue of $183.7 million, compared to a net income of $18.7 million on revenue of $118.6 million in the same period last year [2] - Ethos plans to sell shares in its upcoming IPO, joining other insurtech companies like Exzeo and Neptune that are also seeking to go public [2] Company Performance - Ethos activated policies on its platform increased by 70% to 94,405 in the first half of 2025 [5] - The company has diversified its offerings to include new insurance and estate-planning products over time [5] - Ethos previously raised $100 million from SoftBank at a valuation of $2.7 billion in 2021 [5] Market Context - The insurance IPO market has been active since May, with several companies going public, although aftermarket performance has varied [3] - Some companies like Accelerant and Slide Insurance are trading below their initial offer prices, while others like American Integrity Insurance and Aspen Insurance have performed well [3][4] - Investors are cautious about the sustainability of public-market performance for upcoming insurance listings, influenced by recent IPO outcomes [4] Underwriting and Listing - Goldman Sachs and J.P. Morgan are the lead underwriters for Ethos's IPO [5] - Ethos is set to list on the Nasdaq under the ticker symbol "LIFE" [5]

Core Viewpoint - Standard Uranium Ltd. has successfully closed the second tranche of its non-brokered private placement, raising gross proceeds of $484,000, and is planning a LIFE Offering to further enhance its capital for exploration projects [2][5][6]. Private Placement Offering - The second tranche involved the issuance of 1,550,000 non-flow-through units at $0.08 each, generating $124,000, and 3,600,000 flow-through units at $0.10 each, generating $360,000 [3]. - The total gross proceeds from both tranches of the Private Placement Offering amount to $1,320,100, with a total of 9,301,250 non-flow-through units and 5,760,000 flow-through units issued [5]. - The company plans to raise a total of $3,500,000 through the completion of additional tranches, with the final tranche expected to close before October 31, 2025 [5][9]. LIFE Offering - The company will offer up to 20,000,000 flow-through units under the Listed Issuer Financing Exemption, which will not be subject to a hold period [6]. - The net proceeds from both the Private Placement Offering and the LIFE Offering are intended for exploration of the company's uranium projects in Saskatchewan and for working capital purposes [8]. Company Overview - Standard Uranium is focused on uranium exploration in the Athabasca Basin, holding interests in over 233,455 acres (94,476 hectares) [10]. - The company's Davidson River Project is highly prospective for basement-hosted uranium deposits, with significant confidence in its exploration model due to recent drilling results [11]. - The eastern Athabasca projects and the Sun Dog project also show high potential for uranium deposits based on historical occurrences and geophysical anomalies [12][13].